CoChat

Mitochondria‐targeted disruptors and inhibitors of cytochrome c/cardiolipin peroxidase complexes: A new strategy in anti‐apoptotic drug discovery

Open access
Kagan, Valerian E., Bayir, Ayse, Bayir, Hulya, Stoyanovsky, Detcho, Borisenko, Grigory G., Tyurina, Yulia Y., Wipf, Peter, Atkinson, Jeffrey, Greenberger, Joel S., Chapkin, Robert S., Belikova, Natalia A. · 2009 · Molecular Nutrition & Food Research
Cited by 90

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Thre critical role of mitochondria in programmed cell death leads to the design of mitochondriotropic agents as a strategy in regulating apoptosis. For anticancer therapy, stimulation of proapoptotic mitochondrial events in tumor cells and their suppression in surrounding normal cells represents a promising paradigm for new therapies. Different approaches targeting regulation of components of mitochondrial antioxidant system such as Mn‐SOD demonstrated significant antitumor efficiency, particularly in combination therapy. This review is focused on a newly discovered early stage of mitochondria‐dependent apoptosis – oxidative lipid signaling involving a mitochondria‐specific phospholipid cardiolipin (CL). Cytochrome c (cyt c) acts as a CL‐specific peroxidase very early in apoptosis. At this stage, the hostile events are still secluded within the mitochondria and do not reach the cytosolic targets. CL oxidation process is required for the release of pro‐apoptotic factors into the cytosol. Manipulation of cyt c interactions with CL, inhibition of peroxidase activity, and prevention of CL peroxidation are prime targets for the discovery of anti‐apoptotic drugs acting before the “point‐of‐no‐return” in the fulfillment of the cell death program. Therefore, mitochondria‐targeted disruptors and inhibitors of cyt c/CL peroxidase complexes and suppression of CL peroxidation represent new strategies in anti‐apoptotic drug discovery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/mnfr.200700402

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 90

Metadata

Authors
Kagan, V. E., Bayir, A., Bayir, H., Stoyanovsky, D., Borisenko, G. G., Tyurina, Y. Y., Wipf, P., Atkinson, J., Greenberger, J. S., Chapkin, R. S., & Belikova, N. A.
Venue
Molecular Nutrition & Food Research
Publisher
Wiley
Published
2008-12-23
Volume
53
Issue
1
Pages
104-114
ISSN
  • 1613-4125 (ISSN-L)
  • 1613-4133
OpenAlex
W2019802526
Cited by
90
References
9
FWCI
2.73
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mitochondria‐targeted disruptors and inhibitors of cytochrome c/cardiolipin peroxidase complexes: A new strategy in anti‐apoptotic drug discovery. https://app.cochat.ai/papers/10.1002/mnfr.200700402
The paper
Kagan, V. E., Bayir, A., Bayir, H., Stoyanovsky, D., Borisenko, G. G., Tyurina, Y. Y., Wipf, P., Atkinson, J., Greenberger, J. S., Chapkin, R. S., & Belikova, N. A. (2009). Mitochondria‐targeted disruptors and inhibitors of cytochrome c/cardiolipin peroxidase complexes: A new strategy in anti‐apoptotic drug discovery. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.200700402

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.